I

Intuitive Surgical

ISRG · NASDAQ · Healthcare

$398.30

$3.31 (-0.83%) today

Loading live data...

Market Cap

$142.70B

24h Volume

$668.4M

P/E Ratio

45.6

52w High

$592.85

52w Low

$332.02

Est. AI Revenue

20%

Loading chart data...

7-Day Sparkline (Static)

Company facts

CEO: David J. Rosa
Founded: 1995
HQ: Sunnyvale, California
Employees: 17,021

Performance

24 Hours-0.83%
7 Days+5.61%
30 Days+5.15%
1 Year-10.29%

About Intuitive Surgical

Intuitive Surgical pioneered robotic-assisted surgery. It makes money selling da Vinci surgical robots to hospitals, then earns recurring revenue from the instruments, accessories, and services each system consumes with every procedure.

Its platform keeps advancing. The da Vinci 5 is its latest surgical robot, the Ion robot handles lung biopsies, AI-assisted surgical planning supports procedure preparation, and My Intuitive AI gives surgeons data and insights from their cases.

Founded in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical trades on the NASDAQ and employs about 17,000 people.

Intuitive Surgical in the AI buildout

Intuitive Surgical anchors the Robotics & Automation and AI Healthcare layers of the AI buildout. It is the dominant franchise in robotic-assisted surgery, and its razor-and-blade model means every procedure on a da Vinci system generates recurring revenue. As a robotics pure play its exposure runs high, though the thesis rests on procedure growth and hospital adoption rather than AI itself: AI features enhance the platform with planning and insights, but the robot franchise is the engine.

ISRG is tracked in Robotics & Automation and AI Healthcare, rated Core on the AI Exposure leaderboard.

By the numbers

52-week range

ISRG trades at $398.30, 25% of the way up its 52-week range of $332.02 to $592.85.

Market cap

Market capitalization is $142.70B, with an AI Exposure Score of 70 out of 100.

Valuation vs peers

Its P/E ratio of 45.6 is above the Robotics & Automation category median of 36.6.

Next earnings

Intuitive Surgical is next expected to report earnings on October 20, 2026.

Market data as of the close on . Prices are end of day, not live.

Frequently asked questions

What does Intuitive Surgical do?

Intuitive Surgical sells da Vinci surgical robots to hospitals for minimally invasive procedures, earning recurring revenue from instruments, accessories, and services. It is the dominant company in robotic-assisted surgery.

How is Intuitive Surgical exposed to AI?

As a robotics pure play with AI enhancement. The da Vinci franchise drives the thesis through procedure growth, with AI adding planning and insights. Supercycle rates it an AI Exposure Score of 70 out of 100.

What are Intuitive Surgical's main products?

The da Vinci 5 surgical robot, the Ion robot for lung procedures, AI-assisted surgical planning tools, and My Intuitive AI, which gives surgeons data from their own cases.

What sector and categories is ISRG in?

Intuitive Surgical is in the Healthcare sector. On Supercycle it is categorized under Robotics & Automation and AI Healthcare, reflecting its surgical robotics platform.

Where is Intuitive Surgical based and who leads it?

Intuitive Surgical is headquartered in Sunnyvale, California, and is led by CEO David J. Rosa. The company was founded in 1995 and employs about 17,000 people.

Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.